Passiflora incarnata Linneaus as an anxiolytic before spinal anesthesia

Journal of Anesthesia

Volumn 26, Issue 1, 2012, Pages 39-44

  Aslanargun, Pinar ^a   Aslan, Eymen ^a   Cuvas, Ozgun ^a   Yuksel, Mustafa Ugur ^a   Dikmen, Bayazit ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Anesthesia; Anxiety; Passiflora incarnata; Spinal

Indexed keywords

ANXIOLYTIC AGENT; PASSIFLORA INCARNATA EXTRACT; PASSIFLORA INCARNATA LINNEAUS EXTRACT; PLACEBO; UNCLASSIFIED DRUG; PLANT EXTRACT;

ADULT; ANXIETY DISORDER; ARTICLE; BRADYCARDIA; CONTROLLED STUDY; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICINAL PLANT; NAUSEA; PASSIFLORA INCARNATA LINNEAUS; POSTOPERATIVE COMPLICATION; PREMEDICATION; PREOPERATIVE PERIOD; PROSPECTIVE STUDY; PSYCHOMOTOR ACTIVITY; RANDOMIZED CONTROLLED TRIAL; RESPIRATION DEPRESSION; SEDATION; SENSORIMOTOR FUNCTION; SHIVERING; SPINAL ANESTHESIA; STATE TRAIT ANXIETY INVENTORY; TRANQUILIZING ACTIVITY; VOMITING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; MIDDLE AGED; PASSIFLORA; PHYTOTHERAPY;

ADULT; ANESTHESIA, SPINAL; ANTI-ANXIETY AGENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PASSIFLORA; PHYTOTHERAPY; PLANT EXTRACTS; PREANESTHETIC MEDICATION; PROSPECTIVE STUDIES;

EID: 84862249767     PISSN: 09138668     EISSN: 14388359     Source Type: Journal    
DOI: 10.1007/s00540-011-1265-6     Document Type: Article

References (23)

1. Höhener D, Blumenthal S, Borgeat A. Sedation and regional anaesthesia in the adult patient. Br J Anaesth. 2008;100:8-16. (Pubitemid 351773426)
2. Dhawan K, Kumar S, Sharma A. Anti-anxiety studies on extracts of Passiflora incarnata Linneaus. J Ethnopharm. 2001;78: 165-70. (Pubitemid 32994786)
3. Mills S, Bone K (eds). Principles and practice of phytotherapy. Edinburgh: Churchill Livingstone; 2000. p. 232-3.
4. Sopranzi N, DeFeo G, Mazzanti G, Tolu L. Biological and electroencephalographic parameters in rats in relation to Passiflora incarnata. Clin Ter. 1990;132:329-33. (Pubitemid 20132380)
5. Akhondzadeh S, Naghavi HR, Vazirian M, Shayeganpour A, Rashidi H, Khani M. Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trials with oxazepam. J Clin Pharm Ther. 2001;26:363-7. (Pubitemid 32989558)
6. Soulimani R, Younus C, Jarmouni S, Bousta D, Misslin R, Mortier F. Behavioral effects of Passiflora incarnata L. and its indole alkaloid and flavonoid derivatives and maltol in the mouse. J Ethnopharmacol. 1997;57:11-20. (Pubitemid 27303468)
7. Grundmann O, Wahling C, Staiger C, Butterweck V. Anxiolytic effects of a passion flower (Passiflora incarnata L.) extract in the elevated plus maze in mice. Pharmazie. 2009;64:63-4.
8. Movafegh A, Alizadeh R, Hajimohamadi F, Esfahani F, Nejatfar M. Preoperative oral Passiflora incarnata reduces anxiety in ambulatory surgery patients: a double-blind, placebo-controlled study. Anesth Analg. 2008;106:1728-32.
9. Grundmann O, Wang J, McGregor GP, Butterweck V. Anxiolytic activity of a phytochemically characterized Passiflora incarnata extract is mediated via the GABAergic system. Planta Med. 2008;74:1769-73.
10. Miyasaka LS, Atallah AN, Soares BG. Passiflora for anxiety disorder. Cochrane Database Syst Rev. 2007;24:CD004518.
11. Ersnst E. Herbal remedies for anxiety-a systematic review of controlled clinical trials. Phytomedicine. 2006;13:205-8.
12. Spielberger CD. Manuel for the State-Trait Anxiety Inventory (Form Y). Palo Alto: Consulting Psychologists Press Inc.; 1983.
13. Goyal N, Ramakrishna B, Bhandarkar S. A comparative evaluation of the characteristics of recovery from anaesthesia with isoflurane and halothane in day-care surgery. Indian J Anaesth. 2006;50:183-6.
14. Caumo W, Schmidt AP, Schneider CN, Bergmann J, Iwamoto CW, Bandeira D, Ferreira MBC. Risk factors for preoperative anxiety in adults. Acta Anaesthesiol Scand. 2001;45:298-307. (Pubitemid 32187533)
15. Cravotta G, Boffa L, Genzini L, Garella D. Phytotherapeutics: an evaluation of the potential of 1000 plants. J Clin Pharm Ther. 2010;35:11-48.
16. Wolfman C, Viola H, Paladini A, Dajas F, Medina JH. Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from Passiflora caerulea. Pharmacol Biochem Behav. 1994;47:1-4.
17. Loli F, Sato CM, Romanini CV, Viaggi Billas-Boas LD, Moraes Santos CA, de Oliveira RMW. Possible involvement of GABAAbenzodiazepine receptor in the anxiolytic-like effect induced by Passiflora actinia extracts in mice. J Ethnopharmacol. 2007;111:308-14. (Pubitemid 46553717)
18. Wohlmuth H, Penman KG, Pearson T, Lehmann RP. Pharmacognosy and chemotypes of passionflower (Passiflora incarnata L.). Biol Pharm Bull. 2010;33:1015-8.
19. Blumenthal M. The Complete German Commission E Monographs. Therapeutic guide to herbal medicines. Austin: American Botanical Council; 1998.
20. Gentili M, Chau Huu P, Enel D, Hollande J, Bonnet F. Sedation depends on the level of sensory block induced by spinal anaesthesia. Br J Anaesth. 1998;81:970-1. (Pubitemid 28561337)
21. Smith GW, Chalmers TM, Nuki G. Vasculitis associated with herbal preparation containing Passiflora extract. Br J Rheumatol. 1993;32:87-8. (Pubitemid 23053608)
22. Fisher AA, Purcell P, Le Couteur DG. Toxicity of Passiflora incarnata L. J Toxicol Clin Toxicol. 2000;38:63-6.
23. Pierre S, Crosbie L, Duttaroy AK. Inhibitory effect of aqueous extracts of some herbs on human platelet aggregation in vitro. Platelets. 2005;16:469-73. (Pubitemid 43109920)